[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Stakeholder](https://github.com/mm80843/T3.5/tree/pages/docs/Stakeholder/index.md) >> Individual ID:PBN__Stakeholder_5 

# __Laboratories__

## Category to which it belongs

* [All individuals engaged in various forms of work, including employees, freelancers, laborers, and professionals.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_244.md)

## Closest similar item

* [Clinical laboratories](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1575.md)
* [Clinical laboratory](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1380.md)
* [Laboratory and research](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1155.md)
* [Laboratory management](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1825.md)
* [Laboratory personnel](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1557.md)
* [Laboratory researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_700.md)
* [Laboratory supervisors](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_698.md)
* [Laboratory technicians](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_688.md)
* [Medical laboratories](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1824.md)
* [Testing laboratories](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1051.md)

## Risk affecting this stakeholder

* [Lack of standardised method for covid-19 measurements](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_16200.md)
* [Lack of standardized testing for uvgi effectiveness](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18062.md)

## Risks that can be mitigated by this stakeholder

* [Accumulation of extraneous nucleic acids during the concentration process of wastewater samples.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1614.md)
* [Assumption of linear relationship between uv dose and percent survival](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2375.md)
* [Assumption of well-mixed room air may not reflect real-world conditions](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_2374.md)
* [Complexity of pcr determination](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3673.md)
* [Complicated sample handling in the laboratory for pcr testing](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5160.md)
* [Development of rt-qpcr assays for sars-cov-2 rna detection in water](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5192.md)
* [Emerging technology built by the transition of functions from biological systems](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5197.md)
* [False-negative results in covid-19 testing](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5199.md)
* [Improper glove usage leading to contamination](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5477.md)
* [Inconsistent quantification of sars-cov-2 in sewage samples](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5478.md)
* [Inconsistent results between different assays when concentrations are low](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5479.md)
* [Lack of sensitivity in experimental methods for capturing all droplets emitted during coughing and sneezing may lead to incomplete understanding of droplet propagation.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6118.md)
* [Lack of standardised method for covid-19 measurements](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7144.md)
* [Limitation to pcr-based methods for virus concentration and detection in wastewater.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10759.md)
* [Limitations of the model used in assessing upper-room uvgi effectiveness](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10761.md)
* [Long turnaround time for covid-19 testing](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11787.md)
* [Low sensitivity of current assays for sars-cov-2 detection in sewage](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11788.md)
* [Optimization of pcr conditions may result in false-positive results.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11789.md)
* [Positive identification of human sars-cov-2 by means of rt-qpcr](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11802.md)
* [Potential contamination of reagents and probes](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12171.md)
* [Reliance on qpcr as the method of choice for detecting sars-cov-2 in wastewater.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12197.md)
* [Survival of viruses in biological fluids such as mucus, feces, and blood](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12220.md)
* [Testing method limitations for viral concentration from water samples](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_16041.md)
* [Uncertain relationship between relative humidity rh and uv inactivation rate of bacterial aerosols.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_16200.md)
* [Uncertainty in the value of the upper-room uv susceptibility constant for sars-cov-2](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17087.md)
* [Untested retention of wastewater samples before the sars-cov-2 pandemic as control.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18116.md)
* [Use of toluene as the target voc for study](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18326.md)
* [Variability in sensitivity of primer/probe sets for sars-cov-2 rna detection](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18335.md)
* [Variation in pmmov levels across samples with a standard deviation of 1.34 c t units](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18336.md)
* [Variation in viral signal degradation during storage at 4 u00b0c](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18616.md)
* [Volumes processed in rna extraction](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18646.md)

## This Stakeholder belongs to this Stakeholder Group

* [Health organisations](https://github.com/mm80843/T3.5/blob/pages/StakeholderGroup/PBN__StakeholderGroup_7.md)
* [Research organisations](https://github.com/mm80843/T3.5/blob/pages/StakeholderGroup/PBN__StakeholderGroup_0.md)

## This Stakeholder belongs to this Stakeholder Subgroup

* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/StakeholderSubgroup/PBN__StakeholderSubgroup_5.md)

## This Stakeholder can get these Benefits from mitigation measures

* [Enhanced accuracy of quantification](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_7.md)
* [Improved quantification capability](https://github.com/mm80843/T3.5/blob/pages/Benef/PBN__Benef_6.md)

## Type of the stakeholder

* [Beneficiary](https://github.com/mm80843/T3.5/blob/pages/Stakeholder_Type/PBN__Stakeholder_Type_0.md)
* [Risk owner](https://github.com/mm80843/T3.5/blob/pages/Stakeholder_Type/PBN__Stakeholder_Type_2.md)

